251 related articles for article (PubMed ID: 23582675)
1. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trial.
Roubille F; Micheau A; Combes S; Thibaut S; Souteyrand G; Cayla G; Bonello L; Lesavre N; Sportouch-Dukhan C; Klein F; Berboucha S; Cade S; Cung TT; Raczka F; Macia JC; Gervasoni R; Cransac F; Leclercq F; Barrère-Lemaire S; Paganelli F; Mottref P; Vernhet Kovacsik H; Ovize M; Piot C
Arch Cardiovasc Dis; 2013 Mar; 106(3):135-45. PubMed ID: 23582675
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
3. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
5. A single-center prospective randomized controlled trial evaluating the safety and efficacy of IntraCoronary Erythropoietin delivery BEfore Reperfusion: gauging infarct size in patients with acute ST-segment elevation myocardial infarction. Study design and rationale of the 'ICEBERG Trial'.
Suh JW; Yoon YE; Oh IY; Yoon CH; Cho YS; Youn TJ; Chae IH; Choi DJ
Contemp Clin Trials; 2013 May; 35(1):145-50. PubMed ID: 23506972
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
7. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
[TBL] [Abstract][Full Text] [Related]
9. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
10. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
[TBL] [Abstract][Full Text] [Related]
11. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
[TBL] [Abstract][Full Text] [Related]
12. Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial.
Hallén J; Petzelbauer P; Schwitter J; Geudelin B; Buser P; Atar D
EuroIntervention; 2010 Apr; 5(8):946-52. PubMed ID: 20542780
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
[TBL] [Abstract][Full Text] [Related]
14. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
[TBL] [Abstract][Full Text] [Related]
15. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
Liu ZB; Fu XH; Wei G; Gao JL
Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study.
Wong DT; Leung MC; Das R; Puri R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
Catheter Cardiovasc Interv; 2012 Nov; 80(5):746-53. PubMed ID: 22422674
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
20. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
Yang XC; Liu Y; Wang LF; Cui L; Wang T; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Liu SH; Zhang L; Jia HM; Vinten-Johansen J; Zhao ZQ
J Invasive Cardiol; 2007 Oct; 19(10):424-30. PubMed ID: 17906344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
